Search research articles
Contact Us
Filters
Showing results (411-420 of 424) with videos related to
Page
of 43
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 1, 2005
Loss of heterozygosity for chromosomes 1p and 16q is an adverse prognostic factor in favorable-histology Wilms tumor: a report from the National Wilms Tumor Study Group
Paul E Grundy, Norman E Breslow, Sierra Li, et al.
BMJ (Clinical Research Ed.)
|
June 8, 2012
Facilitated physical activity as a treatment for depressed adults: randomised controlled trial
Melanie Chalder, Nicola J Wiles, John Campbell, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 20, 2006
Treatment of anaplastic histology Wilms' tumor: results from the fifth National Wilms' Tumor Study
Jeffrey S Dome, Cecilia A Cotton, Elizabeth J Perlman, et al.
Health Technology Assessment (Winchester, England)
|
March 9, 2012
A pragmatic randomised controlled trial to evaluate the cost-effectiveness of a physical activity intervention as a treatment for depression: the treating depression with physical activity (TREAD) trial
M Chalder, N J Wiles, J Campbell, et al.
Annals of Surgery
|
February 10, 2010
Long-term outcomes for infants with very low risk Wilms tumor treated with surgery alone in National Wilms Tumor Study-5
Robert C Shamberger, James R Anderson, Norman E Breslow, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 5, 2001
Treatment with nephrectomy only for small, stage I/favorable histology Wilms' tumor: a report from the National Wilms' Tumor Study Group
D M Green, N E Breslow, J B Beckwith, et al.
Transplant Immunology
|
May 7, 2020
Immediate impact of COVID-19 on transplant activity in the Netherlands
A P J de Vries, I P J Alwayn, R A S Hoek, et al.
Pediatric Blood & Cancer
|
March 21, 2006
Treatment of Wilms tumor relapsing after initial treatment with vincristine and actinomycin D: a report from the National Wilms Tumor Study Group
Daniel M Green, Cecilia A Cotton, Marcio Malogolowkin, et al.
Pediatric Blood & Cancer
|
June 1, 2007
Treatment of Wilms tumor relapsing after initial treatment with vincristine, actinomycin D, and doxorubicin. A report from the National Wilms Tumor Study Group
Marcio Malogolowkin, Cecilia A Cotton, Daniel M Green, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 28, 1998
The International Neuroblastoma Risk Groups (INRG): a preliminary report
R P Castleberry, J Pritchard, P Ambros, et al.
Page
of 43
Search research articles
Search
Showing results (411-420 of 424) with videos related to
Sort By:
Page
of 43
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 1, 2005
Loss of heterozygosity for chromosomes 1p and 16q is an adverse prognostic factor in favorable-histology Wilms tumor: a report from the National Wilms Tumor Study Group
Paul E Grundy, Norman E Breslow, Sierra Li, et al.
BMJ (Clinical Research Ed.)
|
June 8, 2012
Facilitated physical activity as a treatment for depressed adults: randomised controlled trial
Melanie Chalder, Nicola J Wiles, John Campbell, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 20, 2006
Treatment of anaplastic histology Wilms' tumor: results from the fifth National Wilms' Tumor Study
Jeffrey S Dome, Cecilia A Cotton, Elizabeth J Perlman, et al.
Health Technology Assessment (Winchester, England)
|
March 9, 2012
A pragmatic randomised controlled trial to evaluate the cost-effectiveness of a physical activity intervention as a treatment for depression: the treating depression with physical activity (TREAD) trial
M Chalder, N J Wiles, J Campbell, et al.
Annals of Surgery
|
February 10, 2010
Long-term outcomes for infants with very low risk Wilms tumor treated with surgery alone in National Wilms Tumor Study-5
Robert C Shamberger, James R Anderson, Norman E Breslow, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 5, 2001
Treatment with nephrectomy only for small, stage I/favorable histology Wilms' tumor: a report from the National Wilms' Tumor Study Group
D M Green, N E Breslow, J B Beckwith, et al.
Transplant Immunology
|
May 7, 2020
Immediate impact of COVID-19 on transplant activity in the Netherlands
A P J de Vries, I P J Alwayn, R A S Hoek, et al.
Pediatric Blood & Cancer
|
March 21, 2006
Treatment of Wilms tumor relapsing after initial treatment with vincristine and actinomycin D: a report from the National Wilms Tumor Study Group
Daniel M Green, Cecilia A Cotton, Marcio Malogolowkin, et al.
Pediatric Blood & Cancer
|
June 1, 2007
Treatment of Wilms tumor relapsing after initial treatment with vincristine, actinomycin D, and doxorubicin. A report from the National Wilms Tumor Study Group
Marcio Malogolowkin, Cecilia A Cotton, Daniel M Green, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 28, 1998
The International Neuroblastoma Risk Groups (INRG): a preliminary report
R P Castleberry, J Pritchard, P Ambros, et al.
Page
of 43